BNO 0.00% 1.0¢ bionomics limited

Ann: Follow-up Analysis from PREVAIL Phase 2 Study of BNC210 in S, page-2

  1. 7,712 Posts.
    lightbulb Created with Sketch. 891
    Obvious question, what the heck is going on here?

    The ASX must be asking the same question.

    From not meeting primary endpoint to being world beaters?

    What’s up doc?
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.